InvestorsHub Logo
Followers 85
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: hutschi post# 326003

Friday, 04/06/2018 2:49:25 PM

Friday, April 06, 2018 2:49:25 PM

Post# of 346182
There looks to be more going on behind this staged BOD exchange where the new front agreed to something in exchange for something and yet, another front says the IP has failed and many research fronts say it is still up in the air for how blocking PS causes a set of events and not blocking PS causes a set of events

The sets of events have known Biomarker qualities that still need to be presented and analyzed with those Biomarker sets of events behind the IP research, trials, etc etc held by PPHM, then CDMO, seemingly then Oncologie ...

As the new BODs sit back and say "oh, we don't know about that past..." lol

Who is Daniel Benjamin? ...must be related to Laura E. Benjamin CEO of Oncologie and I don't seem to see his name yet on nothing Oncologie related
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News